Search results
Results from the WOW.Com Content Network
The Asthma Life Impact Scale (ALIS) measure is a disease-specific patient reported outcome questionnaire which assesses the impact that asthma has on a patient’s quality of life. [1] The questionnaire has 22 items, [1] which goes beyond earlier focus on the symptoms, functioning and environmental triggers of asthma and includes emotional ...
Reported clinical prevalences of IA for adults range from around 40% in a primary care practice [133] to 70% in a speciality practice treating mainly severe asthma patients. [135] Additional information on the clinical prevalence of IA in adult-onset asthma is unavailable because clinicians are not trained to elicit this type of history ...
A variety of validated surveys exist for healthcare providers to use for measuring a patient's health-related quality of life. The results are then used to help determine treatment options for the patient based on past results from other patients, [41] and to measure intra-individual improvements in QoL pre- and post-treatment.
In 2000-2001 asthma prevalence was monitored at 6.5%; by 2010-2011 a 4.3% increase was shown, with asthma prevalence totaling 10.8% of Canada's population. [29] Furthermore, asthma prevalence varies among the provinces of Canada; the highest prevalence is Ontario at 12.1%, and the lowest is Nunavut at 3.8%. [29]
AERD affects an estimated 0.3–0.9% of the general population in the US, including around 7% of all asthmatics, about 14% of adults with severe asthma, and ~5-10% of patients with adult onset asthma. [2] [3] [8] AERD is uncommon among children, with around 6% of patients, predominantly female, reporting disease onset during childhood. [9]
Remaining life expectancy is the expected remaining number of years of life as a function of current age. [1] Life expectancy at birth is indicated above the "0" current age.
The Asthma and Allergy Foundation of America (AAFA) is the leading patient organization for people with asthma and allergies and the oldest asthma and allergy patient group in the world. AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education ...
Idiopathic pulmonary fibrosis (IPF) synonymous with cryptogenic fibrosing alveolitis [5] is a rare, progressive illness of the respiratory system, characterized by the thickening and stiffening of lung tissue, associated with the formation of scar tissue.